Author:
Papp Zoltán,Csapó Kálmán,Pollesello Piero,Haikala Heimo,Édes István
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Reference133 articles.
1. Levosimendan increases L-type Ca2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes;Ajiro;Eur J Pharmacol,2002
2. The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendan;Antila;Int J Clin Pharmacol Ther,1998
3. Site dependent bioavailability and metabolism of levosimendan in dogs;Antila;Eur J Pharm Sci,1999
4. Studies on psychomotoric effects and pharmacokinetic interactions of the new calcium sensitizing drug levosimendan and ethanol;Antila;Arzneimittelforschung,1997
5. Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin;Antila;Eur J Clin Pharmacol,2000
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献